cardin distributor fare better
healthcar short term
updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
smallest youngest three lead
pharmaceut medic distributor
employe across own oper facil leas
oper facil around world cardin health
platform address comprehens sourc distribut
need manufactur provid global scale sheer
pharmaceut volum enabl compani negoti
competit price manufactur pharmaci
provid pbm effici provid access vast
portfolio drug core busi roughli revenu
focus pharmaceut distribut balanc
revenu contract manufactur distribut medic
suppli handl roughli one third drug
sold unit state compani oper effici
highli regul environ provid insul
drug price drug mix gener versu brand drug volum
larg drive core busi pharmaceut distribut
servic deceler pharmaceut drug growth due
slower brand drug inflat shift mix favor gener
drug lower price point slower introduct blockbust
drug increas provid negoti leverag custom
concentr put oper margin pressur
howev high cost pharmaceut drug off-set
declin introduct brand drug overal
oper margin rel displac brand drug like
lower similar two largest distributor compani
grown signific size regular acquisit
like necessari supplement growth order off-set
slower growth
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
cardin health third-largest global logist provid engag
wholesal pharmaceut medic product similar two
peer compani evolv time becom entrench
sourc distribut brand-nam gener pharmaceut
relat servic hospit healthcar system pharmaci
ambulatori surgeri center clinic laboratori physician offic
acquisit cardin health abil manufactur
commod product certain medic devic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
assign fair valu estim cardin health
impli fiscal enterpris adjust ev/ebitda
multipl nearli time free cash flow yield
dividend yield short term believ healthcar
distributor benefit unpreced volum
relat bolster profit
revenu driver price volum mix
disclos made sever assumpt project
industri growth except potenti extern
market shock anticip market share shift
dramat near term result anticip
overal annual top-lin growth roughli larg
benefit growth specialti pipelin
increas number therapi age popul
brand drug
compon growth varieti factor includ
slower growth introduct new
drug neg less extent gener deflat
lower spend hepat prescript opioid
factor net anticip industri revenu
growth roughli similar industri
rang accord iqvia express script
consist overal pharmaceut spend trend
expect revenu grow declin
approxim compound-annual-growth-rate past three year
histor revenu growth continu lumpi due
mix drug introduct inflat acquisit
overal drug volum skew toward gener similar
industri averag roughli howev lower
gener price point would translat roughli half
optumrx top five custom account
approxim total consolid
past three four year oper margin
industri declin oper margin cardin
declin
model oper margin declin
fiscal next five year declin
revenu anticip continu pressur
pharmaceut distribut headwind
ration medic devic oper
part valuat framework addit
base-cas dcf model bull case bear case
valuat scenario critic debat
surround compani abil entrench exist
partnership manufactur
negoti provid
financ
inventori manag servic
provid negoti provid specialti drug distribut
base current high level custom concentr
increas competit environ potenti
regulatori chang believ limit upsid
base scenario per share
bull-cas fair valu estim per share
scenario revenu growth
basi point higher base scenario result
bear-cas fair valu estim per share
scenario pharmaceut distribut revenu declin
oper margin project declin basi
point due increas pressur
custom renew headwind signific
chang legisl regulatori environ
extern shock factor would increas uncertainti
downsid scenario
uncertainti rate pharmaceut
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
abil navig highli regul drug market scale
also enabl compani negoti behalf
provid retail pharmaci requir infrastructur
regulatori hurdl requir logist manag
insul compani new entrant
distributor world along
repres market
time role pharmaceut distributor evolv
increas number new therapi format
govern regulatori organ regulatori
requir
licensur manufactur retail
pharmaci pharmaceut distributor
evolut compani continu invest
physic infrastructur provid logist support
highli effici manner compani scale also
provid abil negoti lower price drug
manufactur across comprehens portfolio gener
brand specialti drug behalf provid acut
hospit clinic mail pharmaci retail
complianc certain financ function provid
manufactur support commerci
infrastructur escal past decad
cardin health invest nearli billion
capit expenditur billion acquisit
billion order strengthen posit matur
autom
cardin health initi found food
focus wholesal drug
manufactur acquisit bailey drug later
decad sinc time compani made seri
acquisit rang autom pill dispens
pyxi medic product manufactur distributor
divis baxter healthcar medic devic
compani divis johnson johnson medtron
distributor stand medium due competit
environ potenti extern shock includ
legisl chang increas price transpar
potenti entranc new competitor
cardin assign narrow-moat rate aris
cost advantag
cardin health
effect oper oligopoli entrench
within custom base three lead distributor
similar differ slightli largest
pharmaceut distributor certain global contract
manufactur capabl vertic integr
provid retail pharmaci chain canada
europ closest pure-play
pharmaceut distributor platform base insid
close provid retail pharmaci cardin
smallest three lead pharmaci
distributor
manufactur capabl medic devic
compani invest infrastructur provid
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
addit sever smaller acquisit also unlik
cardin
certain contract manufactur acquisit
product distribut limit transport asset
commod natur compani distribut servic
reflect low oper margin despit
low margin compani histor gener roic
larg due scale growth driven strong
drug price inflat increas therapi
current lack price transpar signific
variat list invoic price day day
price volatil regulatori complianc recal
provid retail pharmaci
infrastructur quickli manag avail inform
negoti competit price manufactur
cardin healthss volum also provid abil
lower price drug manufactur
increment scale compani abil provid
assist inventori manag complianc
financ convers compani also support
commerci new drug deliveri product
secur moat scale
uncertain drug price environ grow
custom leverag limit moat narrow recent
howev pharmaceut revenu declin
slower inflat shift revenu mix increas
gener versu brand drug meanwhil margin
declin like part due increas negoti
leverag custom driven healthcar provid
consolid top five custom
repres revenu oper margin declin
exacerb ratino product
intern locat medic devic acquisit
factor weigh roic trend like
persist long term view
despit short-term benefit unpreced
demand surg short term due coronarviru
insul provid compani amass
physic infrastructur complex regulatori environ
overal market pressur like resum due
declin reimburs healthcar consolid
deceler growth overal pharmaceut market
build reimburs pressur manufactur
provid press focu cost contain
result pharmaceut distribut client
activ solicit bid negoti better price
commod servic distributor also includ
client gener sourc joint ventur red oak sourc
walgreen claruson
healthcar consolid also
increas concentr pharmaceut distribut
custom top five cardin custom
repres roughli revenu market
pressur increas leverag pharmaceut
distributor custom like largest contributor
deterior overal industri margin
declin consecut last sever year even
provid manufactur appear test direct
altern may limit could also
signific declin pharmaceut market
growth caus distributor seek altern
channel acquisit entri new
area outsid core compet proven costli
specif opportunist enter
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
medic devic busi acquisit cordi
sinc acquisit compani ration
product offer exit roughli countri cardin
continu expand new area maintain
lead posit off-set declin core busi
execut regulatori risk increas concern
addit extern shock highli contest
reduct rebat increas price transpar
would diminish pharmaceut distributor
valu negoti transpar price
provid manufactur would less like need middl
man negoti rate would give custom
leverag renegoti distribut contract
amazon may immedi threat next sever
year discount altogeth
compani signific resourc appear
method gather expertis effect compet
healthcar distribut amazon signific inventori
manag expertis quietli accumul
core piec need compet pharmaceut
distributor includ pillpak state distributor licens
joint ventur jp morgan berkshir
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
key drug distributor handl
third pharmaceut distribut market
compani infrastructur provid scale abil
effect negoti price provid
inventori
oth compani servic enabl provid
manufactur focu core busi
outsourc logist drug highli
requir high sunk cost low oper margin
provid barrier entri highli matur market
leverag
declin reimburs matur market could
limit futur growth put pressur profit
compani continu make acquisit
outsid core compet seek altern
channel growth execut regulatori risk
oextern shock potenti legisl action
increas drug price transpar entranc
disrupt competitor could disrupt current
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
believ cardin health enjoy posit solid
financi strength aris strong balanc sheet
posit matur market fiscal
compani billion cash equival off-set
billion debt debt capit ratio less
gross leverag time adjust ebitda free
cash flow gener million billion
fiscal exclud acquisit sale
acquisit seek new channel fuel growth
manag spent roughli billion averag
acquisit four fiscal year repres
doubl histor trend annual common stock
dividend averag million past year
acceler million fiscal
dividend yield repurchas
billion worth stock fiscal fiscal
million buyback fiscal manag
roughli billion remain share repurchas
compani oper matur oligopoli loss
regulatori chang signific litig opioid entrant
new competitor signific resourc overal
market dynam could reduc abil negoti
pressur drug price pose risk compani
includ deflat gener drug price increas gener
mix slower growth pharmaci pipelin lower
spend hepat opioid risk could eman
propos govern rule seek increas
transpar drug price elimin rebat
cost drug current pass-through
revenu basi pharmaci wholesal
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
compens although pharmaci distributor would
opportun negoti drugmak provid
uncertainti abil negoti
industri rate paid current
transpar continu consolid
pharmaci could impact compani abil negoti
lower price cornerston servic render
compani although potenti threat new
competitor immin amazon compani
signific inventori manag expertis
quietli accumul core piec need compet
pharmaceut distributor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
new york mellon corp
share
fund
share
fund
assign standard stewardship
scott barnhart presid global manufactur
suppli chain join compani last year
presid global suppli chain group purchas
organ respons
suppli chain procur global countri
compani oper profession servic facil
busi prior join barnhart respons
intern suppli chain manufactur
conagra food held rang role span
london-bas diageo plc lead custom servic
plan manufactur procur distributor
oper north america latin america
move corpor posit suppli chain
inform technolog consult pricewaterhousecoop
steve blazejewski presid medic solut
medic product suppli chain servic hospit
laboratori physician offic surgeri center
site care blazejewski join august
compani acquir patient
recoveri busi instrument facilit
purchas signific impact
success integr prior join
compani blazejewski senior vice presid
presid global patient monitor recoveri pmr
busi blazejewski nearli year sale
market execut leadership experi within
medic devic industri tenur patient
recoveri busi evolv root sherwood
medic chang tyco healthcar covidien
craig cowman execut vice presid global sourc
manag strateg sourc supplier manag
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
compani also held executive-level
commerci clinic role sunesi corpor
dendreon corpor imclon incorpor abraxi
overal leader season divers
background pharmaceut distribut see
enterprisewid capac lead team
respons sourc pharmaceut medic
product across nation brand cardin brand
well raw materi indirect good prior assum
role cowman serv compani senior vice
presid strateg sourc product manag
respons develop
deploy cardin health brand gener
consum health sourc price sell strategi
pharmaceut segment cowman
year develop
wide rang manag experi perspect
varieti area within cardin health includ
market sale telesal purchas
victor crawford chief execut offic
pharmaceut segment segment
distribut brand gener pharmaceut specialti
pharmaceut over-the-count healthcar
consum product crawford came
wide rang experi world
respect compani recent role
chief oper offic healthcar
educ busi dine join
crawford serv presid field oper
pepsi-cola beverag compani guid field leadership
team canada mexico initi join
pepsi-cola bottl compani work
varieti role financ sale appoint
vice presid gener manag greater
chicago divis pepsi-cola gener bottler inc
depinto presid cardin health specialti
solut one fastest-grow busi cardin
depinto spent past year focus
commerci specialti drug market past role
includ sale market leadership posit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
term suppli chain pull take
base account healthcar provid remain
stretch address unpreced
volum gross charg hospit set could
high billion associ pandem
influenza cost accord fair health although
region doubl count may inflat estim
agre direct surg expect unusu
high volum translat short-term gain
distributor anticip advers mix shift toward
commod item hoard suppli increas
charges/fe associ special handl
highli demand product net neutral revenu
perform penalti like waiv expect
volum fall bottom line distributor
model scale longer term anticip mix volum
return histor norm provid focu
anticip cardin health
realiz increas profit near
term maintain long-term outlook fair valu
estim cardin health rais
rais normal
ep rais
normal ep
convers believ walgreen abl
scale effici roll strateg
partnership like slower expect
consum brick mortar compani like incur
higher staf shrinkag overhead store theft
offset higher gross margin flux
profit front end hoard item work
system foot traffic like strain
increas consum confid on-line option
result trim fiscal estim fair valu
estim compani maintain attract
dividend yield
gener tailwind traction initi feb
quarter ep ahead capitaliq consensu
expect intern revenu estim
billion incorpor inflect gener price
stabil medic surgic
anticip sequenti million reduct interest
expens associ defer compens
lower effect tax rate strong gener tailwind
initi traction long-term cost save initi
prove bright spot quarter provid
manag confid increas non-gaap ep
guidanc prior midpoint
maintain narrow moat rate increas fair
valu estim reflect improv
revenu increas year year healthi
growth drug distribut attribut broad base
strength gener sourc price volum pull
new product launch lesser extent
growth specialti drug partial off-set contract
renew headwind medic result flat slightli
short intern expect current inventori
suppli chain anticip weather roughli two
month demand bolster compani valu
suppli chain
expect oper margin tick contract
distribut partial off-set stabil medic margin
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
manag confirm plan obtain million
million cost save initi expect fiscal
balanc realiz next sever year
manag also complet million acceler
share repurchas quarter provid slight
boost voluntari recal million surgic gown
associ surgic pack like disrupt implement
strateg initi resum back half
full-year rais provid boost industri
share maintain fair valu estim jan
previou guidanc midpoint boost share price
three distributor -- cardin
-- toward high driver
guidanc rais reson market growth trend
comment healthcar peer suggest stabil
gener price mid-single-digit brand
continu strength specialti expand role
pharmaceut distributor stronger-than-
expect posit market reaction departur
overal investor pessim segment
fuel continu opioid litig drug polici
best posit distributor provid initi step
improv coordin care evolut value-
base reimburs remain cautiou distributor
group whole
lower gross margin
gener ahead expect better-than-expect
distribut volum increas focu cost control
partial off-set
incorpor lower rate contract renew
largest two client smallest
competit environ believ cardin
continu squeez retail custom
manufactur maintain fair valu estim
narrow moat rate cardin share close slightli
week yet share price one year ago
roughli high share like
remain volatil compani gain foot smallest
three major drug distributor increasingli
competit environ lesser extent opioid
reflect
strength core pharmaceut market includ
continu double-digit growth specialti subseg
increas fiscal normal ep estim
reflect stronger initi
expect top-lin growth back half fiscal year
gener aid better-than-expect cost save
benefit maintain long-term growth rate
slim profit group fair valu
estim share although
overal revenu grew larg drive growth
pharmaceut distribut servic medic revenu
stabil grew compani push at-
home servic somewhat off-set divestitur prior
year distribut growth slightli stronger
expect overal market trend stabil client
contract renew like pose headwind despit
better-than-expect earn larg attribut
lower-than-expect oper expens manag
maintain annual ep guidanc
manag expect headwind renegoti
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
smaller custom contract
expens due anticip increas infrastructur
invest improv effici second-quart result
anticip dip first quarter overal
requir up-front payment rather spread
multipl year manag compani
cover revisit sensit fair valu estim
figur releas maintain no-moat
high uncertainti rate fair valu estim teva
settlement bellweth feder trial
provid much-need relief teva oct
instead kick much-await feder opioid trial
oct would influenc outcom
case million settlement four
five defend three distributor teva
two ohio counti affect opioid epidem
cuyahoga summit announc court
initi teva term disclos includ
cash payment million donat
million opioid treatment medic three-year
period understand teva also settl principl
north carolina pennsylvania tennesse texa
increment inform forthcom although
guidanc provid extrapol
announc payment tent settlement provid
investor relief sinc market price
financ crunch settlement meaning step
toward global settlement remov teva
defend track litig schedul proceed
earli share close nearli news
landmark settlement ahead feder court kickoff
surpris public pharmaceut compani take
step distanc highli charg
polit matter remov largest overhang
share due time constraint move piec
initi settlement probabl came premium
continu believ increment settlement
pleas see aug oct note background
decade-old opioid content pharmaceut
month suspens wall street journal report
settlement involv payment billion three
major pharmaceut distributor time
period although term defend particip
appear fluid landmark settlement ahead
oct feder court kick surpris public
pharmaceut suppli compani want distanc
highli charg polit matter
remov largest overhang respect share
summar aug note decade-old
content pharmaceut suppli chain
culmin standoff ohio feder court
lawsuit repres state citi
counti accus drug manufactur activ market
addict drug pharmaceut distributor fail
detect/report suspici opioid order mani
defend case gener drug manufactur
pharmaceut distributor retail pharmaci
coverag drug manufactur spend signific dollar
market brand drug like crux civil
case unlik brand drug gener significantli
cheaper formul sold base price
activ market result think gener
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
manufactur face lower penalti settl
rel smaller amount brand opioid
indic previous believ settlement
would requir up-front payment dollar services/
product rather could spread multipl year
think make potenti settlement
manag compani coverag
factor smaller payment shorter time period
may modestli adjust fair valu estim revisit
sensit firm settlement figur releas
howev expect impact on-going oper
moat rate
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end june
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
